Marpai (MRAI) Competitors

$2.00
-0.10 (-4.76%)
(As of 12:17 PM ET)

MRAI vs. NMHI, ATER, APCX, PMEC, SWAG, GMM, HKIT, DLPN, AREN, and OG

Should you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Nature's Miracle (NMHI), Aterian (ATER), AppTech Payments (APCX), Primech (PMEC), Stran & Company, Inc. (SWAG), Global Mofy Metaverse (GMM), Hitek Global (HKIT), Dolphin Entertainment (DLPN), The Arena Group (AREN), and Onion Global (OG). These companies are all part of the "business services" sector.

Marpai vs.

Nature's Miracle (NASDAQ:NMHI) and Marpai (NASDAQ:MRAI) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

Nature's Miracle has higher earnings, but lower revenue than Marpai.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nature's Miracle$8.93M1.55N/AN/AN/A
Marpai$37.15M0.56-$28.75M-$3.19-0.63

Nature's Miracle has a beta of -0.6, suggesting that its stock price is 160% less volatile than the S&P 500. Comparatively, Marpai has a beta of 5.39, suggesting that its stock price is 439% more volatile than the S&P 500.

Nature's Miracle has a net margin of 0.00% compared to Nature's Miracle's net margin of -69.48%.

Company Net Margins Return on Equity Return on Assets
Nature's MiracleN/A N/A N/A
Marpai -69.48%N/A -68.67%

In the previous week, Nature's Miracle had 2 more articles in the media than Marpai. MarketBeat recorded 2 mentions for Nature's Miracle and 0 mentions for Marpai. Marpai's average media sentiment score of 0.81 beat Nature's Miracle's score of 0.70 indicating that Nature's Miracle is being referred to more favorably in the media.

Company Overall Sentiment
Nature's Miracle Positive
Marpai Positive

Marpai has a consensus price target of $6.00, indicating a potential upside of 203.03%. Given Nature's Miracle's higher possible upside, analysts plainly believe Marpai is more favorable than Nature's Miracle.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nature's Miracle
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Marpai
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Marpai received 2 more outperform votes than Nature's Miracle when rated by MarketBeat users.

CompanyUnderperformOutperform
Nature's MiracleN/AN/A
MarpaiOutperform Votes
2
66.67%
Underperform Votes
1
33.33%

94.6% of Nature's Miracle shares are owned by institutional investors. Comparatively, 49.8% of Marpai shares are owned by institutional investors. 36.2% of Nature's Miracle shares are owned by company insiders. Comparatively, 61.3% of Marpai shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Nature's Miracle and Marpai tied by winning 6 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MRAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MRAI vs. The Competition

MetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ Exchange
Market Cap$20.62M$2.26B$6.37B$7.99B
Dividend YieldN/A1.99%3.05%3.91%
P/E Ratio-0.6312.1828.4814.81
Price / Sales0.565.851,071.9673.68
Price / CashN/A12.6324.3829.27
Price / Book-1.163.434.664.56
Net Income-$28.75M$74.19M$115.14M$212.43M
7 Day Performance-11.11%2.31%10.26%4.87%
1 Month Performance-14.16%0.63%13.54%9.25%
1 Year Performance-23.07%-24.46%14.59%10.45%

Marpai Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NMHI
Nature's Miracle
0 of 5 stars
$0.85
flat
N/AN/A$22.35M$8.93M0.0012Gap Up
ATER
Aterian
0 of 5 stars
$2.90
-6.1%
N/A-55.4%$22.24M$142.57M-0.35114Positive News
Gap Down
High Trading Volume
APCX
AppTech Payments
0 of 5 stars
$0.96
+3.2%
N/A-50.8%$23.58M$500,000.00-0.9518Gap Up
PMEC
Primech
0 of 5 stars
$0.67
-4.3%
N/AN/A$23.75MN/A0.003,133Positive News
Gap Down
SWAG
Stran & Company, Inc.
0 of 5 stars
$1.29
-4.4%
N/A-18.1%$24.01M$75.89M-64.50118Gap Down
GMM
Global Mofy Metaverse
0 of 5 stars
$0.93
-4.1%
N/AN/A$24.09M$26.89M0.0038
HKIT
Hitek Global
0 of 5 stars
$1.46
+8.1%
N/A-83.8%$21.01M$4.56M0.0048
DLPN
Dolphin Entertainment
0 of 5 stars
$1.13
-2.6%
N/A-41.7%$20.98M$43.12M-0.69245Gap Down
High Trading Volume
AREN
The Arena Group
0 of 5 stars
$0.84
-1.2%
N/A-77.2%$25.01M$244.20M-0.33441Earnings Report
Gap Down
OG
Onion Global
0 of 5 stars
N/AN/AN/A$25.02M$2.04B0.00796Gap Up

Related Companies and Tools

This page (NASDAQ:MRAI) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners